Asiatic Laboratories Limited (DSE:ASIATICLAB)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
36.30
-0.80 (-2.16%)
At close: Mar 27, 2025
-28.82%
Market Cap 4.44B
Revenue (ttm) 1.47B
Net Income (ttm) 268.56M
Shares Out 122.39M
EPS (ttm) 3.06
PE Ratio 11.87
Forward PE n/a
Dividend 1.00 (2.75%)
Ex-Dividend Date Nov 21, 2024
Volume 318,458
Average Volume 455,876
Open 37.00
Previous Close 37.10
Day's Range 36.10 - 37.00
52-Week Range 27.80 - 79.40
Beta n/a
RSI 46.06
Earnings Date May 14, 2025

About Asiatic Laboratories

Asiatic Laboratories Limited manufactures and markets pharmaceutical products in Bangladesh and internationally. The company offers products in the categories of antihistamines and respiratory care; cardiac and eye care; antibiotics, antifungals and antiprotozoals; vitamins and minerals; antiulcerants and antiemetics; dermatological products; antipsychotics and tranquilizers; and non-steroidal anti-inflammatory drugs. It distributes its products through sales distribution centers and a store. The company also exports its products. Asiatic Labor... [Read more]

Industry Pharmaceutical Preparations
Founded 1970
Employees 777
Stock Exchange Dhaka Stock Exchange
Ticker Symbol ASIATICLAB
Full Company Profile

Financial Performance

In 2022, Asiatic Laboratories's revenue was 1.47 billion, an increase of 1.48% compared to the previous year's 1.45 billion. Earnings were 268.56 million, a decrease of -16.21%.

Financial Statements

News

There is no news available yet.